Actavis Confirms Merger Talks With Warner Chilcott

It's official -- sort of.

On Friday, shares of branded pharmaceutical manufacturer Warner Chilcott (NASDAQ: WCRX  ) jumped 20% in response to rumors that the company was in talks to sell itself to larger rival Actavis (NYSE: ACT  ) . Warner also reported steady earnings, where a decline had been expected, and reiterated full-year guidance.

The companies initially declined to comment on the speculation, but toward the end of the trading day, Actavis finally broke the silence, confirming that it "has entered into early-stage discussions with Warner Chilcott plc regarding a potential combination of the two companies." No agreement has been reached, however, and Actavis said it will say nothing further, beyond confirming that the talks are in progress.

That fact alone seems to be making investors happy, however. But close of trading, Warner's shares were still up 20% at $18.01, and Actavis was up more than 12% itself, trading at $119.86.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2425148, ~/Articles/ArticleHandler.aspx, 4/19/2014 8:54:37 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement